null

SMILES: Cc1cnc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)s1

InChI Key: InChIKey=MTJOGVCHXBGIKO-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454179   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454179 (US10717708, Example 26 | US11186544, Example 26) Show SMILES Cc1cnc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)s1 Show InChI InChI=1S/C23H23FN4O4S2/c1-14-13-25-23(33-14)27-22(30)26-18-7-5-11-28(21(18)29)19-10-9-15(12-17(19)24)16-6-3-4-8-20(16)34(2,31)32/h3-4,6,8-10,12-13,18H,5,7,11H2,1-2H3,(H2,25,26,27,30)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	380	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454179 (US10717708, Example 26 | US11186544, Example 26) Show SMILES Cc1cnc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)s1 Show InChI InChI=1S/C23H23FN4O4S2/c1-14-13-25-23(33-14)27-22(30)26-18-7-5-11-28(21(18)29)19-10-9-15(12-17(19)24)16-6-3-4-8-20(16)34(2,31)32/h3-4,6,8-10,12-13,18H,5,7,11H2,1-2H3,(H2,25,26,27,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	210	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454179 (US10717708, Example 26 | US11186544, Example 26) Show SMILES Cc1cnc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)s1 Show InChI InChI=1S/C23H23FN4O4S2/c1-14-13-25-23(33-14)27-22(30)26-18-7-5-11-28(21(18)29)19-10-9-15(12-17(19)24)16-6-3-4-8-20(16)34(2,31)32/h3-4,6,8-10,12-13,18H,5,7,11H2,1-2H3,(H2,25,26,27,30)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	380	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454179 (US10717708, Example 26 | US11186544, Example 26) Show SMILES Cc1cnc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)s1 Show InChI InChI=1S/C23H23FN4O4S2/c1-14-13-25-23(33-14)27-22(30)26-18-7-5-11-28(21(18)29)19-10-9-15(12-17(19)24)16-6-3-4-8-20(16)34(2,31)32/h3-4,6,8-10,12-13,18H,5,7,11H2,1-2H3,(H2,25,26,27,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	210	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair